Purchase of RadLink will result in ‘a substantial lessening of competition’.
PETALING JAYA: In a sign of the increasing enforcement of anti-competitive regulations in this part of the world, IHH Healthcare Bhd’s plan to buy out a Singapore-based diagnostic and molecular imaging service provider has been blocked by the Competition Commission of Singapore (CCS) – the first such move by the regulator there.
Already a subscriber? Log in.
Win a prize this Mother's Day by subscribing to our annual plan now! T&C applies.
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!